January 27, 2021
Alexza Pharmaceuticals, backed by their parent company, Ferrer, is working to develop products for the acute treatment of underserved medical needs in neuroscience. The company is currently conducting two significant Phase IIb clinical trials and is seeking an industry expert to manage the overall clinical operations within the organization. The clinical operations leader, reporting to the Vice President of Research and Development, will oversee the Phase IIb clinical studies in a progressive and innovative culture. In order to secure a passionate and strong clinical operations leader, Alexa retained The Chase Group to execute this search. Known for its industry knowledge and vast network, The Chase Group is poised to identify and secure the high caliber talent needed to build out and grow the clinical operations function within Alexza. For more information, please contact karen@chasegroup.com.
